Ulcerative colitis: open trials in Netherlands

23 open trials have a site in Netherlands. Registry data; only the trial team decides who can take part.

NCT06937086
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Trial Treatment · Phase 3 · Eli Lilly and Company
Amsterdam UMC Locatie VUMC, Amsterdam · Radboudumc, Nijmegen · Ikazia Ziekenhuis, Rotterdam · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-11-04
NCT07186101
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Trial Treatment · Phase 2 · Eli Lilly and Company
Radboudumc, Nijmegen · Elisabeth-Tweesteden Ziekenhuis, Tilburg
Registry updated 2026-11-04
NCT07577856
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Amsterdam UMC Stichting, Amsterdam · Radboud universitair medisch centrum Stichting, Nijmegen · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Stichting Elisabeth-TweeSteden Ziekenhuis, Tilburg · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-11-03
NCT07012395
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.
Amsterdam UMC Stichting, Amsterdam · Zuyderland Medisch Centrum Stichting, Geleen · Radboud universitair medisch centrum Stichting, Nijmegen · Stichting Elisabeth-TweeSteden Ziekenhuis, Tilburg
Registry updated 2026-10-27
NCT07184996
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Sanofi
Nijmegen
Registry updated 2026-10-23
NCT07463183
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
Amsterdam UMC Stichting, Amsterdam · Radboud universitair medisch centrum Stichting, Nijmegen
Registry updated 2026-10-23
NCT07185009
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Sanofi
Amsterdam
Registry updated 2026-10-16
NCT07647640
Prospective Evaluation of Flare Detection in IBD With Digital Biomarkers: Bring Your Own Device Study
Research · Maastricht University Medical Center
Maastricht UMC, Maastricht · Franciscus Hospital, Rotterdam · Jeroen Bosch Hospital, 's-Hertogenbosch
Registry updated 2026-10-13
NCT06405087
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Trial Treatment · Phase 3 · Takeda
Radboud universitair medisch centrum Stichting, Nijmegen
Registry updated 2026-10-09
2025-522338-30-00
LY4268989 (MORF-057) Co-Administered with Mirikizumab in Adults with Moderately to Severely Active Ulcerative Colitis: A Phase 2 Study
Trial Treatment · Phase 2 · Eli Lilly & Co.
Radboud universitair medisch centrum Stichting, Nijmegen · Stichting Elisabeth-TweeSteden Ziekenhuis, Tilburg
Registry updated 2026-10-07
NCT04844606
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Trial Treatment · Phase 3 · Eli Lilly and Company
Erasmus Medisch Centrum, Rotterdam
Registry updated 2026-10-07
NCT07582458
Modafinil for Debilitating Fatigue in Quiescent Inflammatory Bowel Disease MODIFI-IBD Trial)
Trial Treatment · Phase 2/3 · Radboud University Medical Center
Rijnstate, Arnhem · Radboudumc, Nijmegen
Registry updated 2026-09-14
NCT05659953
LMT503 First-in-human SAD, MAD, and FE Study
Trial Treatment · Phase 1 · Lmito Therapeutics Inc.
ICON plc Company - Early Development Services, Groningen
Registry updated 2026-09-01
NCT03571373
PIBD-SETQuality: the Inception Cohort and Safety Registry
Research · Erasmus Medical Center
Erasmus MC - Sophia Children's Hospital, Rotterdam
Registry updated 2026-08-11
NCT06100289
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Trial Treatment · Phase 3 · Takeda
Stichting Radboud Universitair Medisch Centrum, Nijmegen
Registry updated 2026-08-03
2025-522834-30-01
Fibroblast markers to tackle fibrosis in immune-mediated inflammatory diseases
Trial Treatment · Phase 2 · Amsterdam UMC Stichting
Amsterdam UMC Stichting, Amsterdam
Registry updated 2026-06-29
NCT06764615
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Trial Treatment · Phase 2 · Takeda
Amsterdam UMC Stichting, Amsterdam · Zuyderland Medisch Centrum Stichting, Geleen · Stichting Elisabeth-TweeSteden Ziekenhuis, Tilburg
Registry updated 2026-05-22
NCT07258641
Fluorescence Imaging of Adalimumab-680LT and Risankizumab-800CW in Inflammatory Bowel Disease
Trial Treatment · Phase 1/2 · University Medical Center Groningen
University Medical Center Groningen, Groningen
Registry updated 2026-01-14
NCT07046468
Smart Pill for Measuring Gut Health in Colon Inflammation and Colon Cancer
Research · Radboud University Medical Center
Radboud University Medical Center, Nijmegen
Registry updated 2025-08-29
NCT03938701
Fluorescence Imaging of IBD and RA Using Adalimumab-800CW
Trial Treatment · Phase 2 · University Medical Center Groningen
University Medical Center Groningen, Groningen
Registry updated 2025-08-19
NCT06606808
Fluorescence Imaging of Risankizumab-800CW in Inflammatory Bowel Disease
Trial Treatment · Phase 1/2 · University Medical Center Groningen
University Medical Center Groningen, Groningen
Registry updated 2025-03-05
NCT04646187
De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease
Trial Treatment · Phase 4 · University Medical Center Groningen
Rijnstate Ziekenhuis Stichting, Arnhem · Catharina Ziekenhuis Stichting, Eindhoven · Universitair Medisch Centrum Groningen, Groningen
Registry updated 2025-01-06
NCT01882205
Comparison Between Chromoendoscopy and Virtual Chromoendoscopy (NBI, I-scan, FICE) for Detection of Neoplasia in Long Standing Ulcerative Colitis
Trial Treatment · Universitaire Ziekenhuizen KU Leuven
Academic Medical center Maastricht, Maastricht
Registry updated 2024-07-10

All Ulcerative colitis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error